Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Vaccines for maternal immunization against Group B Streptococcus disease: WHO perspectives on case ascertainment and case definitions.

Seale AC, Baker CJ, Berkley JA, Madhi SA, Ordi J, Saha SK, Schrag SJ, Sobanjo-Ter Meulen A, Vekemans J.

Vaccine. 2019 Aug 14;37(35):4877-4885. doi: 10.1016/j.vaccine.2019.07.012. Epub 2019 Jul 11. Review.

2.

Multistate analysis of prospective Legionnaires' disease cluster detection using SaTScan, 2011-2015.

Edens C, Alden NB, Danila RN, Fill MA, Gacek P, Muse A, Parker E, Poissant T, Ryan PA, Smelser C, Tobin-D'Angelo M, Schrag SJ.

PLoS One. 2019 May 30;14(5):e0217632. doi: 10.1371/journal.pone.0217632. eCollection 2019.

3.

The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations.

Vekemans J, Crofts J, Baker CJ, Goldblatt D, Heath PT, Madhi SA, Le Doare K, Andrews N, Pollard AJ, Saha SK, Schrag SJ, Smith PG, Kaslow DC.

Vaccine. 2019 May 27;37(24):3190-3198. doi: 10.1016/j.vaccine.2019.04.039. Epub 2019 Apr 25. Review.

4.

Surveillance for incidence and etiology of early-onset neonatal sepsis in Soweto, South Africa.

Velaphi SC, Westercamp M, Moleleki M, Pondo T, Dangor Z, Wolter N, von Gottberg A, Shang N, Demirjian A, Winchell JM, Diaz MH, Nakwa F, Okudo G, Wadula J, Cutland C, Schrag SJ, Madhi SA.

PLoS One. 2019 Apr 10;14(4):e0214077. doi: 10.1371/journal.pone.0214077. eCollection 2019.

5.

Epidemiology of Invasive Group B Streptococcal Infections Among Nonpregnant Adults in the United States, 2008-2016.

Francois Watkins LK, McGee L, Schrag SJ, Beall B, Jain JH, Pondo T, Farley MM, Harrison LH, Zansky SM, Baumbach J, Lynfield R, Snippes Vagnone P, Miller LA, Schaffner W, Thomas AR, Watt JP, Petit S, Langley GE.

JAMA Intern Med. 2019 Apr 1;179(4):479-488. doi: 10.1001/jamainternmed.2018.7269.

PMID:
30776079
6.

Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance.

Nanduri SA, Petit S, Smelser C, Apostol M, Alden NB, Harrison LH, Lynfield R, Vagnone PS, Burzlaff K, Spina NL, Dufort EM, Schaffner W, Thomas AR, Farley MM, Jain JH, Pondo T, McGee L, Beall BW, Schrag SJ.

JAMA Pediatr. 2019 Mar 1;173(3):224-233. doi: 10.1001/jamapediatrics.2018.4826. Erratum in: JAMA Pediatr. 2019 Mar 1;173(3):296.

PMID:
30640366
7.

Group B streptococcal disease: unmet needs in high-income countries.

Schrag SJ.

Lancet Infect Dis. 2019 Jan;19(1):8-10. doi: 10.1016/S1473-3099(18)30604-2. Epub 2018 Nov 26. No abstract available.

PMID:
30497954
8.

Causes and incidence of community-acquired serious infections among young children in south Asia (ANISA): an observational cohort study.

Saha SK, Schrag SJ, El Arifeen S, Mullany LC, Shahidul Islam M, Shang N, Qazi SA, Zaidi AKM, Bhutta ZA, Bose A, Panigrahi P, Soofi SB, Connor NE, Mitra DK, Isaac R, Winchell JM, Arvay ML, Islam M, Shafiq Y, Nisar I, Baloch B, Kabir F, Ali M, Diaz MH, Satpathy R, Nanda P, Padhi BK, Parida S, Hotwani A, Hasanuzzaman M, Ahmed S, Belal Hossain M, Ariff S, Ahmed I, Ibne Moin SM, Mahmud A, Waller JL, Rafiqullah I, Quaiyum MA, Begum N, Balaji V, Halen J, Nawshad Uddin Ahmed ASM, Weber MW, Hamer DH, Hibberd PL, Sadeq-Ur Rahman Q, Mogan VR, Hossain T, McGee L, Anandan S, Liu A, Panigrahi K, Abraham AM, Baqui AH.

Lancet. 2018 Jul 14;392(10142):145-159. doi: 10.1016/S0140-6736(18)31127-9. Epub 2018 Jul 6.

9.

Obesity, Diabetes, and the Risk of Invasive Group B Streptococcal Disease in Nonpregnant Adults in the United States.

Pitts SI, Maruthur NM, Langley GE, Pondo T, Shutt KA, Hollick R, Schrag SJ, Thomas A, Nichols M, Farley M, Watt JP, Miller L, Schaffner W, Holtzman C, Harrison LH.

Open Forum Infect Dis. 2018 Jun 8;5(6):ofy030. doi: 10.1093/ofid/ofy030. eCollection 2018 Jun.

10.

Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola.

Conteh MA, Goldstein ST, Wurie HR, Gidudu J, Lisk DR, Carter RJ, Seward JF, Hampton LM, Wang D, Andersen LE, Arvay M, Schrag SJ, Dawson P, Fombah AE, Petrie CR, Feikin DR, Russell JBW, Lindblad R, Kargbo SAS, Samai M, Mahon BE.

J Infect Dis. 2018 May 18;217(suppl_1):S33-S39. doi: 10.1093/infdis/jiy061.

PMID:
29788347
11.

Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola.

Jarrett OD, Seward JF, Fombah AE, Lindblad R, Jalloh MI, El-Khorazaty J, Dawson P, Burton D, Zucker J, Carr W, Bah MM, Deen GF, George PM, James F, Lisk DR, Pratt D, Russell JBW, Sandy JD, Turay P, Hamel MJ, Schrag SJ, Walker RE, Samai M, Goldstein ST.

J Infect Dis. 2018 May 18;217(suppl_1):S24-S32. doi: 10.1093/infdis/jiy042.

12.

The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak.

Samai M, Seward JF, Goldstein ST, Mahon BE, Lisk DR, Widdowson MA, Jalloh MI, Schrag SJ, Idriss A, Carter RJ, Dawson P, Kargbo SAS, Leigh B, Bawoh M, Legardy-Williams J, Deen G, Carr W, Callis A, Lindblad R, Russell JBW, Petrie CR, Fombah AE, Kargbo B, McDonald W, Jarrett OD, Walker RE, Gargiullo P, Bash-Taqi D, Gibson L, Fofanah AB, Schuchat A; STRIVE Study Team.

J Infect Dis. 2018 May 18;217(suppl_1):S6-S15. doi: 10.1093/infdis/jiy020. Erratum in: J Infect Dis. 2018 Jul 2;218(3):508-507.

13.

Implementing a Multisite Clinical Trial in the Midst of an Ebola Outbreak: Lessons Learned From the Sierra Leone Trial to Introduce a Vaccine Against Ebola.

Carter RJ, Idriss A, Widdowson MA, Samai M, Schrag SJ, Legardy-Williams JK, Estivariz CF, Callis A, Carr W, Webber W, Fischer ME, Hadler S, Sahr F, Thompson M, Greby SM, Edem-Hotah J, Momoh RM, McDonald W, Gee JM, Kallon AF, Spencer-Walters D, Bresee JS, Cohn A, Hersey S, Gibson L, Schuchat A, Seward JF.

J Infect Dis. 2018 May 18;217(suppl_1):S16-S23. doi: 10.1093/infdis/jix657.

14.

Health Conditions in an Adult Population in Sierra Leone: Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).

Fombah AE, Goldstein ST, Jarrett OD, Jalloh MI, El-Khorazaty J, Lisk DR, Legardy-Williams J, Pratt DA, George PM, Russell JBW, Schrag SJ, Dawson P, Deen GF, Carr W, Lindblad R, James F, Bah MM, Yillia JF, Sandy JD, Turay PE, Conteh MA, Slutsker L, Mahon BE, Samai M, Seward JF.

J Infect Dis. 2018 May 18;217(suppl_1):S75-S80. doi: 10.1093/infdis/jix603.

PMID:
29788342
15.

Mycoplasma pneumoniae Among Children Hospitalized With Community-acquired Pneumonia.

Kutty PK, Jain S, Taylor TH, Bramley AM, Diaz MH, Ampofo K, Arnold SR, Williams DJ, Edwards KM, McCullers JA, Pavia AT, Winchell JM, Schrag SJ, Hicks LA.

Clin Infect Dis. 2019 Jan 1;68(1):5-12. doi: 10.1093/cid/ciy419.

16.

Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001-2015.

Sigaúque B, Kobayashi M, Vubil D, Nhacolo A, Chaúque A, Moaine B, Massora S, Mandomando I, Nhampossa T, Bassat Q, Pimenta F, Menéndez C, Carvalho MDG, Macete E, Schrag SJ.

PLoS One. 2018 Jan 19;13(1):e0191193. doi: 10.1371/journal.pone.0191193. eCollection 2018.

17.

Cost-effectiveness of maternal GBS immunization in low-income sub-Saharan Africa.

Russell LB, Kim SY, Cosgriff B, Pentakota SR, Schrag SJ, Sobanjo-Ter Meulen A, Verani JR, Sinha A.

Vaccine. 2017 Dec 14;35(49 Pt B):6905-6914. doi: 10.1016/j.vaccine.2017.07.108. Epub 2017 Nov 10.

18.

Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children.

Seale AC, Bianchi-Jassir F, Russell NJ, Kohli-Lynch M, Tann CJ, Hall J, Madrid L, Blencowe H, Cousens S, Baker CJ, Bartlett L, Cutland C, Gravett MG, Heath PT, Ip M, Le Doare K, Madhi SA, Rubens CE, Saha SK, Schrag SJ, Sobanjo-Ter Meulen A, Vekemans J, Lawn JE.

Clin Infect Dis. 2017 Nov 6;65(suppl_2):S200-S219. doi: 10.1093/cid/cix664.

19.

Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States.

Kim SY, Nguyen C, Russell LB, Tomczyk S, Abdul-Hakeem F, Schrag SJ, Verani JR, Sinha A.

Vaccine. 2017 Oct 27;35(45):6238-6247. doi: 10.1016/j.vaccine.2017.08.085. Epub 2017 Sep 23.

PMID:
28951085
20.

Group B Streptococcus among Pregnant Women and Newborns in Mirzapur, Bangladesh: Colonization, Vertical Transmission, and Serotype Distribution.

Saha SK, Ahmed ZB, Modak JK, Naziat H, Saha S, Uddin MA, Islam M, Baqui AH, Darmstadt GL, Schrag SJ.

J Clin Microbiol. 2017 Aug;55(8):2406-2412. doi: 10.1128/JCM.00380-17. Epub 2017 May 17.

21.

WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016.

Kobayashi M, Schrag SJ, Alderson MR, Madhi SA, Baker CJ, Sobanjo-Ter Meulen A, Kaslow DC, Smith PG, Moorthy VS, Vekemans J.

Vaccine. 2019 Nov 28;37(50):7307-7314. doi: 10.1016/j.vaccine.2016.12.029. Epub 2016 Dec 22.

22.

Epidemiology of Invasive Early-Onset Neonatal Sepsis, 2005 to 2014.

Schrag SJ, Farley MM, Petit S, Reingold A, Weston EJ, Pondo T, Hudson Jain J, Lynfield R.

Pediatrics. 2016 Dec;138(6). pii: e20162013.

23.

Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries.

Kobayashi M, Vekemans J, Baker CJ, Ratner AJ, Le Doare K, Schrag SJ.

F1000Res. 2016 Sep 22;5:2355. eCollection 2016. Review.

24.

Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research.

Fitchett EJA, Seale AC, Vergnano S, Sharland M, Heath PT, Saha SK, Agarwal R, Ayede AI, Bhutta ZA, Black R, Bojang K, Campbell H, Cousens S, Darmstadt GL, Madhi SA, Meulen AS, Modi N, Patterson J, Qazi S, Schrag SJ, Stoll BJ, Wall SN, Wammanda RD, Lawn JE; SPRING (Strengthening Publications Reporting Infection in Newborns Globally) Group.

Lancet Infect Dis. 2016 Oct;16(10):e202-e213. doi: 10.1016/S1473-3099(16)30082-2. Epub 2016 Sep 12. Review.

PMID:
27633910
25.

Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya.

Seale AC, Koech AC, Sheppard AE, Barsosio HC, Langat J, Anyango E, Mwakio S, Mwarumba S, Morpeth SC, Anampiu K, Vaughan A, Giess A, Mogeni P, Walusuna L, Mwangudzah H, Mwanzui D, Salim M, Kemp B, Jones C, Mturi N, Tsofa B, Mumbo E, Mulewa D, Bandika V, Soita M, Owiti M, Onzere N, Walker AS, Schrag SJ, Kennedy SH, Fegan G, Crook DW, Berkley JA.

Nat Microbiol. 2016 May 23;1(7):16067. doi: 10.1038/nmicrobiol.2016.67.

26.

Implementing an Ebola Vaccine Study - Sierra Leone.

Widdowson MA, Schrag SJ, Carter RJ, Carr W, Legardy-Williams J, Gibson L, Lisk DR, Jalloh MI, Bash-Taqi DA, Kargbo SA, Idriss A, Deen GF, Russell JB, McDonald W, Albert AP, Basket M, Callis A, Carter VM, Ogunsanya KR, Gee J, Pinner R, Mahon BE, Goldstein ST, Seward JF, Samai M, Schuchat A.

MMWR Suppl. 2016 Jul 8;65(3):98-106. doi: 10.15585/mmwr.su6503a14.

PMID:
27387395
27.

Disease Burden of Group B Streptococcus Among Infants in Sub-Saharan Africa: A Systematic Literature Review and Meta-analysis.

Sinha A, Russell LB, Tomczyk S, Verani JR, Schrag SJ, Berkley JA, Mohammed M, Sigauque B, Kim SY; GBS Vaccine Cost-Effectiveness Analysis in Sub-Saharan Africa Working Group.

Pediatr Infect Dis J. 2016 Sep;35(9):933-42. doi: 10.1097/INF.0000000000001233. Review.

28.

Aetiology of Neonatal Infection in South Asia (ANISA): An Initiative to Identify Appropriate Program Priorities to Save Newborns.

Saha SK, El Arifeen S, Schrag SJ.

Pediatr Infect Dis J. 2016 May;35(5 Suppl 1):S6-8. doi: 10.1097/INF.0000000000001099. No abstract available.

PMID:
27070067
29.

Development and Implementation of the ANISA Labeling and Tracking System for Biological Specimens.

Connor NE, Hossain T, Rahman QS, Islam MS, Islam M, Hossain B, McGee L, Diaz MH, Schrag SJ, El Arifeen S, Saha SK; ANISA Methods Group.

Pediatr Infect Dis J. 2016 May;35(5 Suppl 1):S29-34. doi: 10.1097/INF.0000000000001103.

PMID:
27070060
30.

Invasive Group B Streptococcal Disease in South Africa: Importance of Surveillance Methodology.

Quan V, Verani JR, Cohen C, von Gottberg A, Meiring S, Cutland CL, Schrag SJ, Madhi SA.

PLoS One. 2016 Apr 7;11(4):e0152524. doi: 10.1371/journal.pone.0152524. eCollection 2016.

31.

Maternal Immunization to Prevent Neonatal Group B Streptococcal Disease: New Progress and Promise.

Schrag SJ.

Obstet Gynecol. 2016 Feb;127(2):199-201. doi: 10.1097/AOG.0000000000001275. No abstract available.

PMID:
26942342
32.

Chorioamnionitis and Culture-Confirmed, Early-Onset Neonatal Infections.

Wortham JM, Hansen NI, Schrag SJ, Hale E, Van Meurs K, Sánchez PJ, Cantey JB, Faix R, Poindexter B, Goldberg R, Bizzarro M, Frantz I, Das A, Benitz WE, Shane AL, Higgins R, Stoll BJ; Eunice Kennedy Shriver NICHD Neonatal Research Network.

Pediatrics. 2016 Jan;137(1). doi: 10.1542/peds.2015-2323. Epub 2015 Dec 30.

33.

Twenty Years of Active Bacterial Core Surveillance.

Langley G, Schaffner W, Farley MM, Lynfield R, Bennett NM, Reingold A, Thomas A, Harrison LH, Nichols M, Petit S, Miller L, Moore MR, Schrag SJ, Lessa FC, Skoff TH, MacNeil JR, Briere EC, Weston EJ, Van Beneden C.

Emerg Infect Dis. 2015 Sep;21(9):1520-8. doi: 10.3201/eid2109.141333.

34.

Active Tracing and Monitoring of Contacts Associated With the First Cluster of Ebola in the United States.

Chung WM, Smith JC, Weil LM, Hughes SM, Joyner SN, Hall EM, Ritch J, Srinath D, Goodman E, Chevalier MS, Epstein L, Hunter JC, Kallen AJ, Karwowski MP, Kuhar DT, Smith C, Petersen LR, Mahon BE, Lakey DL, Schrag SJ.

Ann Intern Med. 2015 Aug 4;163(3):164-73. doi: 10.7326/M15-0968.

PMID:
26005809
35.

Survey of American obstetricians regarding group B streptococcus: opinions and practice patterns.

Edwards RK, Tang Y, Raglan GB, Szychowski JM, Schulkin J, Schrag SJ.

Am J Obstet Gynecol. 2015 Aug;213(2):229.e1-7. doi: 10.1016/j.ajog.2015.03.047. Epub 2015 Mar 26.

PMID:
25816787
36.

Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008(1).

Cutland CL, Schrag SJ, Thigpen MC, Velaphi SC, Wadula J, Adrian PV, Kuwanda L, Groome MJ, Buchmann E, Madhi SA.

Emerg Infect Dis. 2015 Apr;21(4):638-45. doi: 10.3201/eid2104.141562.

37.

US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011.

Hicks LA, Bartoces MG, Roberts RM, Suda KJ, Hunkler RJ, Taylor TH Jr, Schrag SJ.

Clin Infect Dis. 2015 May 1;60(9):1308-16. doi: 10.1093/cid/civ076. Epub 2015 Mar 5.

PMID:
25747410
38.

vanG element insertions within a conserved chromosomal site conferring vancomycin resistance to Streptococcus agalactiae and Streptococcus anginosus.

Srinivasan V, Metcalf BJ, Knipe KM, Ouattara M, McGee L, Shewmaker PL, Glennen A, Nichols M, Harris C, Brimmage M, Ostrowsky B, Park CJ, Schrag SJ, Frace MA, Sammons SA, Beall B.

MBio. 2014 Jul 22;5(4):e01386-14. doi: 10.1128/mBio.01386-14.

39.

Early-onset group B streptococcal disease in the United States: potential for further reduction.

Verani JR, Spina NL, Lynfield R, Schaffner W, Harrison LH, Holst A, Thomas S, Garcia JM, Scherzinger K, Aragon D, Petit S, Thompson J, Pasutti L, Carey R, McGee L, Weston E, Schrag SJ.

Obstet Gynecol. 2014 Apr;123(4):828-37. doi: 10.1097/AOG.0000000000000163.

PMID:
24785612
40.

Two cases of invasive vancomycin-resistant group B streptococcus infection.

Park C, Nichols M, Schrag SJ.

N Engl J Med. 2014 Feb 27;370(9):885-6. doi: 10.1056/NEJMc1308504. No abstract available.

41.

Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa.

Kim SY, Russell LB, Park J, Verani JR, Madhi SA, Cutland CL, Schrag SJ, Sinha A.

Vaccine. 2014 Apr 7;32(17):1954-63. doi: 10.1016/j.vaccine.2014.01.062. Epub 2014 Feb 11.

PMID:
24530145
42.

Optimization of Multiple Pathogen Detection Using the TaqMan Array Card: Application for a Population-Based Study of Neonatal Infection.

Diaz MH, Waller JL, Napoliello RA, Islam MS, Wolff BJ, Burken DJ, Holden RL, Srinivasan V, Arvay M, McGee L, Oberste MS, Whitney CG, Schrag SJ, Winchell JM, Saha SK.

PLoS One. 2013 Jun 21;8(6):e66183. doi: 10.1371/journal.pone.0066183. Print 2013.

43.
44.

The burden and severity of illness due to 2009 pandemic influenza A (H1N1) in a large US city during the late summer and early fall of 2009.

Doshi SS, Stauffer KE, Fiebelkorn AP, Lafond KE, Davidson HA, Apostolou A, Taylor TH Jr, Smith W, Karcz AN, Watson JR, Openo KP, Brooks JG, Zheteyeva Y, Schrag SJ, Fry AM.

Am J Epidemiol. 2012 Sep 15;176(6):519-26. Epub 2012 Sep 5.

PMID:
22952308
45.

Maternal HIV infection and vertical transmission of pathogenic bacteria.

Cutland CL, Schrag SJ, Zell ER, Kuwanda L, Buchmann E, Velaphi SC, Groome MJ, Adrian PV, Madhi SA; PoPS trial team.

Pediatrics. 2012 Sep;130(3):e581-90. Epub 2012 Aug 6.

PMID:
22869824
46.

Risk factors for neonatal sepsis and perinatal death among infants enrolled in the prevention of perinatal sepsis trial, Soweto, South Africa.

Schrag SJ, Cutland CL, Zell ER, Kuwanda L, Buchmann EJ, Velaphi SC, Groome MJ, Madhi SA; PoPS Trial Team.

Pediatr Infect Dis J. 2012 Aug;31(8):821-6. doi: 10.1097/INF.0b013e31825c4b5a.

PMID:
22565291
47.

Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants.

Shane AL, Hansen NI, Stoll BJ, Bell EF, Sánchez PJ, Shankaran S, Laptook AR, Das A, Walsh MC, Hale EC, Newman NS, Schrag SJ, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.

Pediatrics. 2012 Apr;129(4):e914-22. doi: 10.1542/peds.2011-0966. Epub 2012 Mar 12.

48.

Clinical sepsis in neonates and young infants, United States, 1988-2006.

Lukacs SL, Schrag SJ.

J Pediatr. 2012 Jun;160(6):960-5.e1. doi: 10.1016/j.jpeds.2011.12.023. Epub 2012 Jan 18. Erratum in: J Pediatr. 2012 Sep;161(3):573.

PMID:
22261508
49.

Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis.

Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AK, Cousens S, Heath PT.

Lancet. 2012 Feb 11;379(9815):547-56. doi: 10.1016/S0140-6736(11)61651-6. Epub 2012 Jan 4. Review.

PMID:
22226047
50.

Serologically confirmed household transmission of 2009 pandemic influenza A (H1N1) virus during the first pandemic wave--New York City, April-May 2009.

Jackson ML, France AM, Hancock K, Lu X, Veguilla V, Sun H, Liu F, Hadler J, Harcourt BH, Esposito DH, Zimmerman CM, Katz JM, Fry AM, Schrag SJ.

Clin Infect Dis. 2011 Sep;53(5):455-62. doi: 10.1093/cid/cir437.

PMID:
21844028

Supplemental Content

Loading ...
Support Center